Flinton Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $324K | Buy |
1,187
+167
| +16% | +$45.6K | 0.01% | 569 |
|
|
2019
Q2 | $544K | Sell |
1,020
-349
| -25% | -$186K | 0.02% | 456 |
|
|
2019
Q1 | $690K | Sell |
1,369
-3,255
| -70% | -$1.64M | 0.02% | 377 |
|
|
2018
Q4 | $2.28M | Buy |
4,624
+881
| +24% | +$434K | 0.09% | 181 |
|
|
2018
Q3 | $3.42M | Buy |
3,743
+3,312
| +768% | +$3.03M | 0.11% | 165 |
|
|
2018
Q2 | $316K | Buy |
431
+293
| +212% | +$215K | 0.01% | 545 |
|
|
2018
Q1 | $219K | Sell |
138
-594
| -81% | -$943K | 0.01% | 624 |
|
|
2017
Q4 | $655K | Buy |
732
+125
| +21% | +$112K | 0.02% | 379 |
|
|
2017
Q3 | $218K | Buy |
607
+82
| +16% | +$29.5K | 0.01% | 597 |
|
|
2017
Q2 | $154K | Buy |
525
+226
| +76% | +$66.3K | 0.01% | 644 |
|
|
2017
Q1 | $105K | Buy |
299
+30
| +11% | +$10.5K | ﹤0.01% | 619 |
|
|
2016
Q4 | $49K | Buy |
+269
| New | +$49K | ﹤0.01% | 721 |
|